The European Commission recently launched a targeted stakeholders consultation on the revision of Annex 1, on manufacturing of sterile medicinal products, of the Eudralex Volume 4. EIPG has reviewed the document and, following feedback from its members, has submitted its comments to the EMA.
Regulatory News- Irritation and sensitization potential of transdermal and topical delivery systems October 11, 2018
- Adhesion with transdermal and topical delivery systems October 11, 2018
- MHRA EU Exit no-deal contingency legislation for the regulation of medicines and medical devices October 5, 2018
- Citizen petitions and petitions for stay of action October 5, 2018
- Contents of a complete submission for threshold analyses and human factors submissions October 2, 2018
- Parliamentary News
- Comprehensive SPC manufacturing waiver needed for European patients and SMEs October 9, 2018
- The situation of the pharmacy market in Germany October 6, 2018
- EU-Ukraine Association Agreement and access to medicines October 6, 2018
- Regulation of the European Parliament and of the Council on health technology assessment October 4, 2018
- Directive of the European Parliament and of the Council on the quality of water intended for human consumption October 2, 2018
